expression was investigated in normal ovarian tissues and ovarian tumors. In the present study, we used competitive reverse transcription\p=n-\polymerase chain reaction\p=n-\Southern blot analysis to evaluate SHBG mRNA levels. The expression of SHBG mRNA was detected in all normal ovaries and benign and malignant ovarian tumors analyzed. There were no significant differences in the mean SHBG mRNA levels among the three types of tissue. The expression in normal ovaries was significantly higher (p < 0.01) in premenopause, suggesting the predominance of a sex steroid hormone effect on ovarian SHBG synthesis. Relative 40 Tsukasamachi, Gifu 500, Japan previous studies it has been suggested that 17/3-estradiol (1-3), progesterone (1, 4) , testosterone and dihydrotestos¬ terone (5) are related to ovarian function, and estrogen, progestin and androgen binding sites have been detected and described in human normal ovary and benign and malignant ovarian tumors (6) (7) (8) (9) (10) (11) (12) (13) . Some ovarian cancers respond favorably to tamoxifen (14) (15) (16) (17) (18) , megestrol acetate (15) and medroxyprogesterone acetate (19) .
Previously it was assumed that the free fraction of serum steroid hormones was biologically active, and the sex hormone-binding globulin (SHBG)-bound fraction was not available within the target cells. In the last decade, SHBG binding sites were detected in the cell membrane of human deciduaf endometrium (20) and prostate (21) . Immunocytochemical detection of SHBG has been reported in human endometrium, prostate (22) and mammary glands (23) , in addition to hepatic cells (24, 25) . Moreover, the expression of SHBG mRNA has been demonstrated in human uterine endometrial and prostatic cancer cell lines (26, 27) and human normal uterine endometrium (28) . These (31) . Peripheral monocytes were isolated from heparinized peripheral blood (32) .
To obtain a standard curve each time, the total RNA (3 µg) and a series of diluted recombinant RNA without non-specific products. The SHBG mRNA was detected in higher expression in human liver as a positive control than in normal ovary (Fig. 3) (Fig. 7) . Especially noteworthy is that all three endometrioid adenocarcinomas were characterized by a relatively high expres¬ sion of mRNA. No correlation was found between SHBG mRNA levels and clinical stages for ovarian cancers (Fig. 8) .
Discussion
The expressions of estrogen and progesterone receptors in human normal ovaries and either benign or malignant ovarian tumors have been described in many studies (6) (7) (8) (9) (10) (11) (12) . In rat or canine ovary, chronic administration of sex steroid hormones (androgen or estrogen) has been shown to induce ovarian neoplasms (33, 34) . It has been reported that tamoxifen (14) (15) (16) (17) (18) , megestrol acetate (15) and medroxyprogesterone acetate (19) (20) (21) (22) (23) (24) (25) . Uterine (36) .
In conclusion, although the present study is preliminary, ovarian malignant tumors may conserve the activity of SHBG-related steroidal mechanisms.
